EZZ Life Science Holdings Limited (ASX:EZZ)

Bally's Revenue

EZZ Life Science Holdings had revenue of 30.29M AUD in the half year ending December 31, 2024, with 100.24% growth. This brings the company's revenue in the last twelve months to 75.03M, up 71.65% year-over-year. In the fiscal year ending June 30, 2024, EZZ Life Science Holdings had annual revenue of 66.44M with 78.88% growth.

• Revenue (ttm): 75.03M
• Revenue Growth: +71.65%
• P/S Ratio: 1.28
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 95.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	66.44M	29.30M	78.88%
Jun 30, 2023	37.14M	22.12M	147.26%
Jun 30, 2022	15.02M	-7.27M	-32.60%
Jun 30, 2021	22.29M	4.32M	24.03%
Jun 30, 2020	17.97M	6.78M	60.62%